Global Non-Invasive Prenatal Screening (NIPS) Market 2025 by Company, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Non-Invasive Prenatal Screening (NIPS) market size was valued at US$ 4655 million in 2024 and is forecast to a readjusted size of USD 8663 million by 2031 with a CAGR of 9.4% during review period.
Non-invasive prenatal screening (NIPS) is an emerging prenatal screening technology with many advantages, including non-invasiveness and high accuracy. As technology continues to advance and the market continues to expand, the development prospects of NIPS look very promising.
First, the market demand for NIPS is growing. With the improvement of peoples health awareness and the popularization of the concept of eugenics and postnatal care, more and more pregnant women choose to undergo prenatal screening. Compared with traditional screening methods, NIPS has higher accuracy and wider applicability, so it is increasingly favored by pregnant women. At the same time, with the full liberalization of the two-child policy, the proportion of older mothers has increased significantly, and the demand for NIPS will further increase.
Secondly, NIPS technology is constantly improving. With the rapid development of gene sequencing technology, the detection accuracy and reliability of NIPS continue to improve. For example, second-generation sequencing technology (NGS) has been widely used in NIPS, which can detect multiple gene mutations simultaneously, thereby improving the accuracy and efficiency of detection. In addition, with the development of artificial intelligence and big data technology, NIPS analysis and interpretation have become more accurate and faster.
However, the development of NIPS also faces some challenges. For example, currently NIPS can only detect some common chromosomal diseases and may not provide accurate predictions for other diseases. In addition, the relatively high cost of NIPS also limits its popularity in some areas. At the same time, the supervision of the accuracy and security of NIPS also needs to be further improved.
In general, although the development of NIPS still faces some challenges, with the continuous advancement of technology and the continuous expansion of the market, its development prospects look very promising. In the future, NIPS may become one of the main means of prenatal screening and play an important role in ensuring the health of mothers and infants.
This report is a detailed and comprehensive analysis for global Non-Invasive Prenatal Screening (NIPS) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Non-Invasive Prenatal Screening (NIPS) market size and forecasts, in consumption value ($ Million), 2020-2031
Global Non-Invasive Prenatal Screening (NIPS) market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Non-Invasive Prenatal Screening (NIPS) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Non-Invasive Prenatal Screening (NIPS) market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-Invasive Prenatal Screening (NIPS)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-Invasive Prenatal Screening (NIPS) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Myriad Genetics, Illumina, Progenity, Natera, Yourgene Health, Roche Sequencing Solutions (RSS), Eurofins LifeCodexx GmbH, Labcorp, PerkinElmer, Harmony, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Non-Invasive Prenatal Screening (NIPS) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Trisomy 21
Trisomy 18
Trisomy 13
Sex Chromosome Aneuploidies
Others
Market segment by Application
Hospital
Clinic
Market segment by players, this report covers
Myriad Genetics
Illumina
Progenity
Natera
Yourgene Health
Roche Sequencing Solutions (RSS)
Eurofins LifeCodexx GmbH
Labcorp
PerkinElmer
Harmony
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Non-Invasive Prenatal Screening (NIPS) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Non-Invasive Prenatal Screening (NIPS), with revenue, gross margin, and global market share of Non-Invasive Prenatal Screening (NIPS) from 2020 to 2025.
Chapter 3, the Non-Invasive Prenatal Screening (NIPS) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Non-Invasive Prenatal Screening (NIPS) market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-Invasive Prenatal Screening (NIPS).
Chapter 13, to describe Non-Invasive Prenatal Screening (NIPS) research findings and conclusion.
Non-invasive prenatal screening (NIPS) is an emerging prenatal screening technology with many advantages, including non-invasiveness and high accuracy. As technology continues to advance and the market continues to expand, the development prospects of NIPS look very promising.
First, the market demand for NIPS is growing. With the improvement of peoples health awareness and the popularization of the concept of eugenics and postnatal care, more and more pregnant women choose to undergo prenatal screening. Compared with traditional screening methods, NIPS has higher accuracy and wider applicability, so it is increasingly favored by pregnant women. At the same time, with the full liberalization of the two-child policy, the proportion of older mothers has increased significantly, and the demand for NIPS will further increase.
Secondly, NIPS technology is constantly improving. With the rapid development of gene sequencing technology, the detection accuracy and reliability of NIPS continue to improve. For example, second-generation sequencing technology (NGS) has been widely used in NIPS, which can detect multiple gene mutations simultaneously, thereby improving the accuracy and efficiency of detection. In addition, with the development of artificial intelligence and big data technology, NIPS analysis and interpretation have become more accurate and faster.
However, the development of NIPS also faces some challenges. For example, currently NIPS can only detect some common chromosomal diseases and may not provide accurate predictions for other diseases. In addition, the relatively high cost of NIPS also limits its popularity in some areas. At the same time, the supervision of the accuracy and security of NIPS also needs to be further improved.
In general, although the development of NIPS still faces some challenges, with the continuous advancement of technology and the continuous expansion of the market, its development prospects look very promising. In the future, NIPS may become one of the main means of prenatal screening and play an important role in ensuring the health of mothers and infants.
This report is a detailed and comprehensive analysis for global Non-Invasive Prenatal Screening (NIPS) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Non-Invasive Prenatal Screening (NIPS) market size and forecasts, in consumption value ($ Million), 2020-2031
Global Non-Invasive Prenatal Screening (NIPS) market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Non-Invasive Prenatal Screening (NIPS) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Non-Invasive Prenatal Screening (NIPS) market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-Invasive Prenatal Screening (NIPS)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-Invasive Prenatal Screening (NIPS) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Myriad Genetics, Illumina, Progenity, Natera, Yourgene Health, Roche Sequencing Solutions (RSS), Eurofins LifeCodexx GmbH, Labcorp, PerkinElmer, Harmony, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Non-Invasive Prenatal Screening (NIPS) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Trisomy 21
Trisomy 18
Trisomy 13
Sex Chromosome Aneuploidies
Others
Market segment by Application
Hospital
Clinic
Market segment by players, this report covers
Myriad Genetics
Illumina
Progenity
Natera
Yourgene Health
Roche Sequencing Solutions (RSS)
Eurofins LifeCodexx GmbH
Labcorp
PerkinElmer
Harmony
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Non-Invasive Prenatal Screening (NIPS) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Non-Invasive Prenatal Screening (NIPS), with revenue, gross margin, and global market share of Non-Invasive Prenatal Screening (NIPS) from 2020 to 2025.
Chapter 3, the Non-Invasive Prenatal Screening (NIPS) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Non-Invasive Prenatal Screening (NIPS) market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-Invasive Prenatal Screening (NIPS).
Chapter 13, to describe Non-Invasive Prenatal Screening (NIPS) research findings and conclusion.
Table of Contents
94 Pages
- 1 Market Overview
- 2 Company Profiles
- 3 Market Competition, by Players
- 4 Market Size Segment by Type
- 5 Market Size Segment by Application
- 6 North America
- 7 Europe
- 8 Asia-Pacific
- 9 South America
- 10 Middle East & Africa
- 11 Market Dynamics
- 12 Industry Chain Analysis
- 13 Research Findings and Conclusion
- 14 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
